Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
The role of systemic markers of inflammation in bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019
The role of inflammatory biomarkers like precursors of COPD stability during long-term follow-up Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Dynamics of inflammation biomarkers in drug sensitive tuberculosis and pneumonia Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
Rimfampicin importance in tuberculosis treatment Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008
Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
The importance of inflammatory markers in sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008
Systemic inflammation in COPD – a role for infection? Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008
The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting Source: International Congress 2016 – Airway biomarkers Year: 2016
Basic factors, influencing treatment efficacy of patients with newly detected sputum positive destructive lung tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 724s Year: 2004
The role of biomarkers and effectiveness of maintenance therapy in stable severe COPD Source: International Congress 2017 – COPD management Year: 2017
The role of biomarkers in the management of severe asthma Source: International Congress 2019 – Severe asthma guidelines: update 2019 Year: 2019
Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
The role of infections in the induction of asthma: genetic and inflammatory drivers Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection Year: 2007
Study of inflammatory markers in sputum positive patients of pulmonary tuberculosis and its response to anti-tubercular treatment Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Which is the most effective inflammatory marker in the diagnosis, severity and treatment follow-up of patients with pneumonia? Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
The clinical and bacteriological basis for initiating a specific treatment Source: Annual Congress 2006 - PG11 - Clinical highlights on tuberculosis Year: 2006